Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › PA › Easton › NPI 1609407444
Lab

Advanced Lab Solutions, LLC

Advanced Lab Solutions, LLC was paid $41K by Medicaid between Nov 2020 and Jan 2022, across 7 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 46% of everything it billed.

33Billing provider infoADVANCED LAB SOLUTIONS, LLC
EASTON, PA 18045
33aNPI1609407444assigned 01/30/2020
28Total paid$41K
24GClaims2,946
24DCodes billed7
24AFirst – last monthNov 2020 – Jan 2022
Compared with peers

Next to other Clinical Medical Laboratory providers in Pennsylvania

Rank by total paid#58 of 95
Median peer was paid$153K
This provider vs. median0.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$5.0K$10K$15K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20202,243$26K
2021689$14K
202214$934.00
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 46% 785 501 $19K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 42% 525 458 $17K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 4.8% 764 442 $2K
99072 3.7% 581 363 $2K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.8% 66 40 $752.00
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 1.7% 126 81 $710.50
99070 <1% 99 54 $90.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialAMIN, ATUL (DIRECTOR)
Same official

Other billing entities under AMIN, ATUL

Full network →
ProviderLocationPaid
Atul K. Amin, MD PCEaston, PA$135.37

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.